115 related articles for article (PubMed ID: 9121613)
21. 5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats.
Abdel-Fattah AF; Matsumoto K; el-Hady KA; Watanabe H
Pharmacol Biochem Behav; 1995 Oct; 52(2):379-84. PubMed ID: 8577805
[TBL] [Abstract][Full Text] [Related]
22. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
Matos FF; Korpinen C; Yocca FD
Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
[TBL] [Abstract][Full Text] [Related]
23. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
24. Effect of ergotamine on serotonin-mediated responses in the rodent and human brain.
Haddjeri N; Seletti B; Gilbert F; de Montigny C; Blier P
Neuropsychopharmacology; 1998 Nov; 19(5):365-80. PubMed ID: 9778659
[TBL] [Abstract][Full Text] [Related]
25. The modulatory action of harmane on serotonergic neurotransmission in rat brain.
Abu Ghazaleh H; Lalies MD; Nutt DJ; Hudson AL
Brain Res; 2015 Feb; 1597():57-64. PubMed ID: 25498864
[TBL] [Abstract][Full Text] [Related]
26. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
27. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus.
Pei Q; Zetterström T; Fillenz M
Neuropharmacology; 1989 Oct; 28(10):1061-6. PubMed ID: 2478921
[TBL] [Abstract][Full Text] [Related]
28. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
29. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
Ge J; Barnes NM
Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
[TBL] [Abstract][Full Text] [Related]
30. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
31. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
O'Connell MT; Portas CM; Sarna GS; Curzon G
Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108
[TBL] [Abstract][Full Text] [Related]
32. Tryptophol-induced change in Brain 5-hydroxytryptamine Metabolism.
Fukumori R; Minegishi A; Satoh T; Kitagawa H; Yanaura S
Psychopharmacology (Berl); 1980; 69(3):243-6. PubMed ID: 6158066
[TBL] [Abstract][Full Text] [Related]
33. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
[TBL] [Abstract][Full Text] [Related]
34. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.
Martin P; Carlsson ML; Hjorth S
Neuroreport; 1998 Sep; 9(13):2985-8. PubMed ID: 9804302
[TBL] [Abstract][Full Text] [Related]
35. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
36. Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism.
Abdel-Fattah AF; Matsumoto K; Gammaz HA; Watanabe H
Pharmacol Biochem Behav; 1995 Oct; 52(2):421-6. PubMed ID: 8577810
[TBL] [Abstract][Full Text] [Related]
37. The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo.
Whitton PS; Fowler LJ
Eur J Pharmacol; 1991 Jul; 200(1):167-9. PubMed ID: 1722752
[TBL] [Abstract][Full Text] [Related]
38. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.
Wegener G; Volke V; Rosenberg R
Br J Pharmacol; 2000 Jun; 130(3):575-80. PubMed ID: 10821785
[TBL] [Abstract][Full Text] [Related]
39. In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.
Bel N; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):475-82. PubMed ID: 7543977
[TBL] [Abstract][Full Text] [Related]
40. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
